A citation-based method for searching scientific literature


List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neuropathological stageing of Alzheimer-related changes.
H Braak, E Braak. Acta Neuropathol 1991
25



The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.
Erika N Cline, Maíra Assunção Bicca, Kirsten L Viola, William L Klein. J Alzheimers Dis 2018
342
18

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.
Dominic M Walsh, Igor Klyubin, Julia V Fadeeva, William K Cullen, Roger Anwyl, Michael S Wolfe, Michael J Rowan, Dennis J Selkoe. Nature 2002
18

Alzheimer's disease: the amyloid cascade hypothesis.
J A Hardy, G A Higgins. Science 1992
18

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status.
Sebastian Palmqvist, Shorena Janelidze, Erik Stomrud, Henrik Zetterberg, Johann Karl, Katharina Zink, Tobias Bittner, Niklas Mattsson, Udo Eichenlaub, Kaj Blennow,[...]. JAMA Neurol 2019
162
12

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
12

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
12

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
12

A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.
Saima Rathore, Mohamad Habes, Muhammad Aksam Iftikhar, Amanda Shacklett, Christos Davatzikos. Neuroimage 2017
218
12

Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer's disease brain tissue.
Ujjayini Ghosh, Kent R Thurber, Wai-Ming Yau, Robert Tycko. Proc Natl Acad Sci U S A 2021
42
12

The amyloid state of proteins in human diseases.
David Eisenberg, Mathias Jucker. Cell 2012
12

Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue.
Marius Kollmer, William Close, Leonie Funk, Jay Rasmussen, Aref Bsoul, Angelika Schierhorn, Matthias Schmidt, Christina J Sigurdson, Mathias Jucker, Marcus Fändrich. Nat Commun 2019
227
12

Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.
Jun-Xia Lu, Wei Qiang, Wai-Ming Yau, Charles D Schwieters, Stephen C Meredith, Robert Tycko. Cell 2013
737
12

Fibril structure of amyloid-β(1-42) by cryo-electron microscopy.
Lothar Gremer, Daniel Schölzel, Carla Schenk, Elke Reinartz, Jörg Labahn, Raimond B G Ravelli, Markus Tusche, Carmen Lopez-Iglesias, Wolfgang Hoyer, Henrike Heise,[...]. Science 2017
492
12



Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics.
William F Goure, Grant A Krafft, Jasna Jerecic, Franz Hefti. Alzheimers Res Ther 2014
106
12

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
Pascale N Lacor, Maria C Buniel, Lei Chang, Sara J Fernandez, Yuesong Gong, Kirsten L Viola, Mary P Lambert, Pauline T Velasco, Eileen H Bigio, Caleb E Finch,[...]. J Neurosci 2004
755
12

Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman primates.
Leticia Forny-Germano, Natalia M Lyra e Silva, André F Batista, Jordano Brito-Moreira, Matthias Gralle, Susan E Boehnke, Brian C Coe, Ann Lablans, Suelen A Marques, Ana Maria B Martinez,[...]. J Neurosci 2014
145
12

A specific amyloid-beta protein assembly in the brain impairs memory.
Sylvain Lesné, Ming Teng Koh, Linda Kotilinek, Rakez Kayed, Charles G Glabe, Austin Yang, Michela Gallagher, Karen H Ashe. Nature 2006
12


Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
M P Lambert, A K Barlow, B A Chromy, C Edwards, R Freed, M Liosatos, T E Morgan, I Rozovsky, B Trommer, K L Viola,[...]. Proc Natl Acad Sci U S A 1998
12

Self-assembly of Abeta(1-42) into globular neurotoxins.
Brett A Chromy, Richard J Nowak, Mary P Lambert, Kirsten L Viola, Lei Chang, Pauline T Velasco, Bryan W Jones, Sara J Fernandez, Pascale N Lacor, Peleg Horowitz,[...]. Biochemistry 2003
424
12

A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.
Takami Tomiyama, Tetsu Nagata, Hiroyuki Shimada, Rie Teraoka, Akiko Fukushima, Hyoue Kanemitsu, Hiroshi Takuma, Ryozo Kuwano, Masaki Imagawa, Suzuka Ataka,[...]. Ann Neurol 2008
305
12

Tau is essential to beta -amyloid-induced neurotoxicity.
Mark Rapoport, Hana N Dawson, Lester I Binder, Michael P Vitek, Adriana Ferreira. Proc Natl Acad Sci U S A 2002
606
12

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.
Yuesong Gong, Lei Chang, Kirsten L Viola, Pascale N Lacor, Mary P Lambert, Caleb E Finch, Grant A Krafft, William L Klein. Proc Natl Acad Sci U S A 2003
821
12

Amyloid β-protein oligomers and Alzheimer's disease.
Eric Y Hayden, David B Teplow. Alzheimers Res Ther 2013
163
12

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.
Sergio T Ferreira, Mychael V Lourenco, Mauricio M Oliveira, Fernanda G De Felice. Front Cell Neurosci 2015
218
12

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
Andre F Batista, Leticia Forny-Germano, Julia R Clarke, Natalia M Lyra E Silva, Jordano Brito-Moreira, Susan E Boehnke, Andrew Winterborn, Brian C Coe, Ann Lablans, Juliana F Vital,[...]. J Pathol 2018
128
12

Neurotoxicity of amyloid β-protein: synaptic and network dysfunction.
Lennart Mucke, Dennis J Selkoe. Cold Spring Harb Perspect Med 2012
662
12

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.
Fernanda G De Felice, Diana Wu, Mary P Lambert, Sara J Fernandez, Pauline T Velasco, Pascale N Lacor, Eileen H Bigio, Jasna Jerecic, Paul J Acton, Paul J Shughrue,[...]. Neurobiol Aging 2008
314
12

The amyloid hypothesis on trial.
Simon Makin. Nature 2018
167
12

Amyloid beta: structure, biology and structure-based therapeutic development.
Guo-Fang Chen, Ting-Hai Xu, Yan Yan, Yu-Ren Zhou, Yi Jiang, Karsten Melcher, H Eric Xu. Acta Pharmacol Sin 2017
508
12

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Brian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, Joshua C Bis, Vincent Damotte, Adam C Naj, Anne Boland, Maria Vronskaya, Sven J van der Lee, Alexandre Amlie-Wolf,[...]. Nat Genet 2019
950
12

Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.
Summer L Bernstein, Nicholas F Dupuis, Noel D Lazo, Thomas Wyttenbach, Margaret M Condron, Gal Bitan, David B Teplow, Joan-Emma Shea, Brandon T Ruotolo, Carol V Robinson,[...]. Nat Chem 2009
657
12


Cell-specific production, secretion, and function of apolipoprotein E.
Maaike Kockx, Mathew Traini, Leonard Kritharides. J Mol Med (Berl) 2018
32
12

A beta oligomers - a decade of discovery.
Dominic M Walsh, Dennis J Selkoe. J Neurochem 2007
12


The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling,[...]. Nature 2016
12


The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
12

Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
Zemin Wang, Rosemary J Jackson, Wei Hong, Walter M Taylor, Grant T Corbett, Arturo Moreno, Wen Liu, Shaomin Li, Matthew P Frosch, Inna Slutsky,[...]. J Neurosci 2017
70
12

Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brain.
Wei Hong, Zemin Wang, Wen Liu, Tiernan T O'Malley, Ming Jin, Michael Willem, Christian Haass, Matthew P Frosch, Dominic M Walsh. Acta Neuropathol 2018
51
12

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
Rachelle S Doody, Ronald G Thomas, Martin Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul S Aisen,[...]. N Engl J Med 2014
993
12

Donanemab in Early Alzheimer's Disease.
Mark A Mintun, Albert C Lo, Cynthia Duggan Evans, Alette M Wessels, Paul A Ardayfio, Scott W Andersen, Sergey Shcherbinin, JonDavid Sparks, John R Sims, Miroslaw Brys,[...]. N Engl J Med 2021
210
12


The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.
Min Xia, Xiaofang Cheng, Ruofan Yi, Dong Gao, Jiaxiang Xiong. Mol Neurobiol 2016
35
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.